admin

Treatment for Contraception Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US Print this page ADELAIDE, Australia, June 24, 2020 /PRNewswire/ — Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the New Drug Application (NDA) for E4/DRSP to prevent pregnancy has been accepted for review by the US Food
0 Comments
Print this page KENILWORTH, N.J.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC) that is not curable by
0 Comments
What have we learned about the coronavirus and what do we still need to find out most urgently? Meg Tirrell talks to Columbia University virologist Angela Rasmussen on “Healthy Returns: The Path Forward”. For more exclusive insights from our reporters and speakers, sign up for our Healthy Returns newsletter to get the latest delivered straight to your inbox weekly.
0 Comments
Coronavirus has killed at least 121,979 people and infected nearly 2.4 million nationwide, according to Johns Hopkins. Florida and Texas announced Wednesday that they’d recorded more than 5,000 new Covid-19 cases the prior day, a new daily record. California reported more than 7,000 cases, obliterating a record hit a day earlier. In Texas, if the
0 Comments
We know that it has been harder for people to exercise over these last several weeks. Christina Lombardi, DPT PT has put together easy exercises to get you moving at home! For the past several Wednesdays we shared exercises with you. Each exercise included descriptive information and a video to demonstrate how to do it. This
0 Comments
In an effort to replicate an experiment conducted over a century ago, systems biologists at Harvard Medical School present compelling evidence confirming at least one single-cell organism—the strikingly trumpet-shaped Stentor roeselii—exhibits a hierarchy of avoidance behaviors. Exposed repeatedly to the same stimulation—in this case a pulse of irritating particles—the organism can in effect “change its
0 Comments
At the American Diabetes Association (ADA) 80th scientific sessions last week, Dr. Ashutosh Subharwal, Department Chair and Director of Department of Electrical and Computer Engineering at Rice University, put together a compelling presentation that showed the benefits of using smartphone sensors to measure behavior-biology pathways and use those findings to assess, treat and improve healthcare
0 Comments
Print this page MUMBAI, India, June 20, 2020 /PRNewswire/ — In a landmark development for COVID-19 patients in India, Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced the launch of antiviral drug Favipiravir (brand name FabiFlu®) for the treatment of mild to moderate COVID-19 patients. Glenmark has received manufacturing and marketing approval from India’s drug regulator, making FabiFlu®
0 Comments
Treatment for Urinary Tract Infection Nabriva Therapeutics Receives Complete Response Letter from FDA on NDA for Contepo (fosfomycin) for injection Print this page DUBLIN, Ireland, June 19, 2020 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced today
0 Comments
Print this page London, UK – 12 June 2020 — ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) has approved Tivicay PD (dolutegravir) tablets for oral suspension, which are used in combination with other antiretroviral
0 Comments
The coronavirus continues to surge in states around the country, mostly in the South and West. Testifying before members of Congress on Tuesday, White House health adviser Dr. Anthony Fauci said parts of the U.S. are beginning to see a “disturbing surge” and described the overall situation as a “mixed bag” across different regions and
0 Comments
WASHINGTON — “Testing” was the word of the day at Tuesday’s House Energy & Commerce Committee hearing on the federal government’s COVID-19 response, with committee members on both sides of the aisle agreeing that the current level of testing was not good enough. “Testing has been a problem since the beginning, and while it’s improved,
0 Comments